156642-19-2Relevant articles and documents
MODIFIED PEPTIDES AND THEIR USE
-
Paragraph 0081; 0084; 0104; 0106, (2020/05/13)
The invention relates to a compound of formula (A) wherein n is an integer from 1 to 6, and R1, R1', R2, R2', R3, R3' are cationic or hydrophobic residues.
Pyrimidine derivatives as IL-8 receptor antagonists
-
Page 29, (2010/02/06)
Compounds containing the pyrimidine nucleus and their use to treat diseases and conditions related to inappropriate Interleukin-8 receptor activity are disclosed. The compounds are of the formula I In these compounds, Q is preferably unsubstituted and substituted heterocyclyl; U is usually hydrogen or fluorine; and V is preferably hydrogen, halogen, alkyl, —O—alkyl or —S-alkyl. A representative example is: